On The Bioinformatics CRO Podcast, we sit down with scientists to discuss interesting topics across biomedical research and to explore what made them who they are today.
Jeff Bizzaro, founder and long-time president of bioinformatics.org, discusses the importance of open source tools and open access in the life sciences.
The Bioinformatics CRO is a fully distributed …
Afshin Beheshti, director of the University of Pittsburgh's new Center for Space Biomedicine, discusses the importance of space biomedicine to understanding human health both in space and on earth.
…
Kenny Workman, co-founder and CTO of LatchBio, discusses his experience building a cloud platform for modern biology and how Latch has grown since our 2022 episode with his co-founder Alfredo Andere.
…Don Alexander, founder and president of GeneCoda, discusses the current climate in hiring for life sciences, trends in remote and hybrid work, and the impact of AI on expectations for candidates.
The…
Dr. Elizabeth Ruzzo, founder and CEO of Adyn, discusses precision medicine for personalized birth control and her commitment to using pioneering endogenomics to make scientific discovery more inclusi…
Max Marchione, Co-Founder of Superpower, discusses his experience founding a health tech company, making concierge medicine accessible to all, and the future of healthcare.
The Bioinformatics CRO is …
Wolfgang Brysch, Co-Founder and CSO of MetrioPharm and iüLabs, discusses longevity, inflammation, and his dual path of research into natural and pharmaceutical remedies.
The Bioinformatics CRO is a f…
Scott Fahrenkrug, founder of Forjazul, discusses his path toward seaweed research, the importance of genetic knowledge for agriculture, and how Kappaphycus alvarezii can help move us into the future.
…Nick Wisniewski, Vice President of Bioinformatics and Data Sciences at Stemson Therapeutics, discusses his journey into cell therapy research, the rise of powerful artificial intelligence tools for b…
Tony Altar, President and COO of Splice Therapeutics, returns to The Bioinformatics CRO Podcast to discuss the present and future of neuropharmacology, skateboarding, and how to make the most of your…
Mo Jain, Founder and CEO of Sapient, discusses the importance of small molecule biomarkers and his approach to biomarker discovery research.
The Bioinformatics CRO is a fully distributed contract re…
Evan Floden, CEO and Co-founder of Seqera Labs, discusses Nextflow, the push for reproducibility in scientific workflows, and his experience as a scientist with a start-up.
The Bioinformatics CRO is …
Linnea Fletcher, Biotechnology Department chair at Austin Community College and Director of the InnovATEBIO National Biotechnology Education Center, discusses training technicians to tackle real worl…
Yuri Deigin, co-founder of YouthBio Therapeutics, discusses developing rejuvenation gene therapies based on partial reprogramming and his role reinvigorating investigations into the origins of SARS-C…
Adam Freund, founder and CEO of Arda Therapeutics, discusses how targeted killing of pathogenic cells could be used to treat chronic disease and aging.
The Bioinformatics CRO is a fully distributed …
Alfredo Andere, co-founder and CEO of Latch Bio, discusses the unique challenges facing young entrepreneurs and the future of cloud computing in biology.
The Bioinformatics CRO is a fully distribute…
Joshua Hare, Professor of Medicine at the University of Miami and co-founder of Longeveron, discusses the regenerative and reparative potential of MSCs and how cell therapies will revolutionize medic…
Alex Shalek, Associate Professor of Chemistry at MIT, discusses new methods and technologies in systems biology that have enabled advances in the diagnosis and treatment of autoimmune diseases and ca…
Jamie Smyth, Associate Professor at Virginia Tech, discusses intercellular communication in the heart and how viral infection of cardiac cells can result in heart disease.
The Bioinformatics CRO is …
Amar Gajjar, world-renowned neuro-oncologist and chair of the Department of Pediatric Medicine at St. Jude Children's Research Hospital, discusses emerging treatments for pediatric brain tumors such …